Dermatofibroma
- Synonyms
- benignes fibröses Histiozytom, Histiozytom
- Specialty
- Dermatology · Skin tumours
- Images
- Clinical 1 · Dermoscopy 1 · Histology 1
- In the app
- 3 flashcards
- Last updated
- 10/2026 · Dr. Pascal Bafteh
Contents
Images (3)

Dermoscopy
HistologyDefinition
Definition & Classification
- Dermatofibroma (synonyms: benign fibrous histiocytoma, in everyday practice simply "histiocytoma") = benign fibrohistiocytic proliferation of the dermis.
- Pathogenesis: predominantly interpreted as a reactive fibroblast proliferation after minor trauma (insect bite, thorn injury, shaving); a subset of lesions is nevertheless clonal.
- Epidemiology: peak incidence 20–50 years of age, women more often; one of the most common benign skin tumours overall.
- Dignity: benign, no risk of malignant transformation, no metastasis — its whole importance lies in the distinction from malignant spindle cell tumours.
Clinical features
- Site: preferentially the lower extremity, especially the lower leg — about two thirds of lesions; women are affected considerably more often.
- Morphology: usually a solitary papule or flat nodule of 0.5–1 cm, firm like a lentil, skin-coloured to reddish-brown, often with a peripheral pigmented rim.
- Palpation: the lesion feels firm and button-like and sits within the dermis — it is tethered to the epidermis but mobile over the subcutis.
- Dimple sign (Fitzpatrick sign): on lateral compression between thumb and index finger the lesion dimples inward — a consequence of its anchoring in the fibrosed corium.
- Symptoms: usually asymptomatic, occasionally itching or tenderness; shaving injuries on the lower leg are a frequent reason for presentation.
Histology
Histology & Immunohistochemistry
- Architecture: an ill-defined dermal proliferation of spindle cells in a storiform-fascicular arrangement, unencapsulated, without tentacular permeation of the subcutaneous fat.
- Collagen trapping: at the periphery the spindle cells surround thick, eosinophilic collagen bundles — a marginal finding typical of dermatofibroma.
- Overlying epidermis: acanthosis with basal hyperpigmentation; follicular and basaloid induction phenomena are also seen.
- Immunohistochemistry: dermatofibroma is factor XIIIa positive, CD34 negative.
- Counter-check dermatofibrosarcoma: dermatofibrosarcoma protuberans (DFSP) shows the mirror image, CD34 positive, factor XIIIa negative, and carries the COL1A1-PDGFB fusion.
Diagnosis
Dermoscopy
- Classic basic pattern (the most frequent of the described patterns): central whitish scar-like patch with a delicate peripheral pigment network.
- The central white zone corresponds histologically to dermal fibrosis with thickened collagen bundles and is the decisive feature separating it from a melanocytic nevus.
- The peripheral network is fine, light brown and fades out gradually — in the prospective series of 412 lesions by Zaballos the most constant single feature.
Differential diagnoses
Image credits for the thumbnails
- Lipoma: James Heilman, MD, “LipomaBack”, CC BY-SA 3.0, via Wikimedia Commons · CC BY-SA 3.0 · Source
- Epidermal cyst (atheroma): unknown (Commons user), “Epidermal Cyst ear”, CC BY-SA 3.0, via Wikimedia Commons · CC BY-SA 3.0 · Source
- Basal cell carcinoma: Bin im Garten, “Basaliom am Nasenrücken 2”, CC BY-SA 3.0, via Wikimedia Commons · CC BY-SA 3.0 · Source
- Melanoma: National Cancer Institute (unknown photographer), “Melanoma (4)”, Public Domain, via Wikimedia Commons · Public domain · Source
- Dermatofibrosarcoma protuberans: Tontonflingueur, “Dermatofibrosarcome facial 01”, CC BY-SA 4.0, via Wikimedia Commons · CC BY-SA 4.0 · Source
Treatment principles
- No treatment is needed; explanation and observation suffice, as the tumour is benign and does not grow destructively.
- Excision is performed only for symptoms, diagnostic uncertainty or enlargement, and then completely down to the subcutis with histological examination, as superficial shave removal leaves the dermal component behind.
- Before cosmetically motivated removal, patients should be informed that the scar, especially on the lower leg, is often more conspicuous than the tumour itself.
Specific treatment regimens with drugs and doses are covered in the DermaFuchs app.
Keep learning in the app
References (selection)
Cross-references
Mentioned in
Keep learning: test yourself
Two questions from the DermaFuchs app on Dermatofibroma – tap an answer.
Question 1 of 2
Which marker is used to identify dermatofibroma in histological samples?
Answer
Correct: Factor XIIIa. Factor XIIIa is expressed in dermatofibromas, helping to distinguish them from other fibrous skin lesions.
Question 2 of 2
Definition & Classification: Dermatofibroma (synonyms: benign fibrous histiocytoma, in everyday practice simply "histiocytoma") = _____.
Answer
Correct: benign fibrohistiocytic proliferation of the dermis. Dermatofibroma (synonyms: benign fibrous histiocytoma, in everyday practice simply "histiocytoma") = benign fibrohistiocytic proliferation of the dermis.
More questions like these – with explanations and spaced repetition – in the app.
Note: This page is intended for medical education and does not replace diagnosis or treatment decisions in individual cases.




